Literature DB >> 18448358

What happens to the DNA vaccine in fish? A review of current knowledge.

Tom Christian Tonheim1, Jarl Bøgwald, Roy Ambli Dalmo.   

Abstract

The primary function of DNA vaccines, a bacterial plasmid DNA containing a construct for a given protective antigen, is to establish specific and long-lasting protective immunity against diseases where conventional vaccines fail to induce protection. It is acknowledged that less effort has been made to study the fate, in terms of cellular uptake, persistence and degradation, of DNA vaccines after in vivo administration. However, during the last year some papers have given new insights into the fate of DNA vaccines in fish. By comparing the newly acquired information in fish with similar knowledge from studies in mammals, similarities with regard to transport, blood clearance, cellular uptake and degradation of DNA vaccines have been found. But the amount of DNA vaccine redistributed from the administration site after intramuscular administration seems to differ between fish and mammals. This review presents up-to-date and in-depth knowledge concerning the fate of DNA vaccines with emphasis on tissue distribution, cellular uptake and uptake mechanism(s) before finally describing the intracellular hurdles that DNA vaccines need to overcome in order to produce their gene product.

Mesh:

Substances:

Year:  2008        PMID: 18448358     DOI: 10.1016/j.fsi.2008.03.007

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  17 in total

Review 1.  Immunological control of fish diseases.

Authors:  Bergljot Magnadottir
Journal:  Mar Biotechnol (NY)       Date:  2010-03-30       Impact factor: 3.619

Review 2.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

3.  Construction of a recombinant eukaryotic vector for a grass carp reovirus VP6 gene and its expression in vitro and in vivo.

Authors:  Yong Zhou; Yu-Ding Fan; Ling-Bing Zeng
Journal:  Virusdisease       Date:  2013-11-30

Review 4.  Immunity to fish rhabdoviruses.

Authors:  Maureen K Purcell; Kerry J Laing; James R Winton
Journal:  Viruses       Date:  2012-01-18       Impact factor: 5.048

5.  P247 and p523: two in vivo-expressed megalocytivirus proteins that induce protective immunity and are essential to viral infection.

Authors:  Jian Zhang; Bao Cun Zhang; Li Sun
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 6.  Strategies and hurdles using DNA vaccines to fish.

Authors:  Linn B Hølvold; Anne I Myhr; Roy A Dalmo
Journal:  Vet Res       Date:  2014-02-19       Impact factor: 3.683

7.  SagE induces highly effective protective immunity against Streptococcus iniae mainly through an immunogenic domain in the extracellular region.

Authors:  Yun Sun; Li Sun; Ming-qing Xing; Chun-sheng Liu; Yong-hua Hu
Journal:  Acta Vet Scand       Date:  2013-11-12       Impact factor: 1.695

8.  A plant 35S CaMV promoter induces long-term expression of luciferase in Atlantic salmon.

Authors:  Tore Seternes; Tom C Tonheim; Anne I Myhr; Roy A Dalmo
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

9.  Bivalent DNA vaccine induces significant immune responses against infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus in rainbow trout.

Authors:  Liming Xu; Jingzhuang Zhao; Miao Liu; Guangming Ren; Feng Jian; Jiasheng Yin; Ji Feng; Hongbai Liu; Tongyan Lu
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

10.  Intramuscular DNA Vaccination of Juvenile Carp against Spring Viremia of Carp Virus Induces Full Protection and Establishes a Virus-Specific B and T Cell Response.

Authors:  Carmen W E Embregts; Dimitri Rigaudeau; Tomáš Veselý; Dagmar Pokorová; Niels Lorenzen; Jules Petit; Armel Houel; Malte Dauber; Heike Schütze; Pierre Boudinot; Geert F Wiegertjes; Maria Forlenza
Journal:  Front Immunol       Date:  2017-10-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.